Detalles de la búsqueda
1.
Interleukin-30 subverts prostate cancer-endothelium crosstalk by fostering angiogenesis and activating immunoregulatory and oncogenic signaling pathways.
J Exp Clin Cancer Res
; 42(1): 336, 2023 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38087324
2.
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival.
J Immunother Cancer
; 11(3)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36927528
3.
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality.
J Hematol Oncol
; 15(1): 145, 2022 10 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36224639
4.
Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
Front Immunol
; 12: 778329, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34975867
5.
Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome.
J Immunother Cancer
; 9(10)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34663639
6.
The C-X-C Motif Chemokine Ligand 1 Sustains Breast Cancer Stem Cell Self-Renewal and Promotes Tumor Progression and Immune Escape Programs.
Front Cell Dev Biol
; 9: 689286, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34195201
Resultados
1 -
6
de 6
1
Próxima >
>>